Vasculitis or vasculitic neuropathy (Q85105): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Changed an Item
‎Changed an Item
 
Property / Collection date
 
13 August 2026
Timestamp+2026-08-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 13 August 2026 / rank
 
Normal rank

Latest revision as of 10:28, 15 August 2026

Vasculitic neuropathy has an acute or subacute onset, occurs more frequently with age and is characterised by an often painful multifocal neuropathy (mononeuritis multiplex). There is a preference for peroneal, posterior tibial, ulnar, median and radial nerves. Also are vasculitic plexopathies more frequent in the lumbosacral than in the brachial plexus. Vasculitic neuropathy appears often in conjunction with systemic features as weight loss and malaise. The vasculitis is characterised by epineurial inflammation, often vessel wall necrosis and inflammation, followed by axonal loss, and patchy fascicular lesions. Treatment with corticosteroids, sometimes in combination with other immunosuppressants, is required to control the inflammatory process and prevent further ischemic nerve damage.
Language Label Description Also known as
default for all languages
ID_1121924544
    English
    Vasculitis or vasculitic neuropathy
    Vasculitic neuropathy has an acute or subacute onset, occurs more frequently with age and is characterised by an often painful multifocal neuropathy (mononeuritis multiplex). There is a preference for peroneal, posterior tibial, ulnar, median and radial nerves. Also are vasculitic plexopathies more frequent in the lumbosacral than in the brachial plexus. Vasculitic neuropathy appears often in conjunction with systemic features as weight loss and malaise. The vasculitis is characterised by epineurial inflammation, often vessel wall necrosis and inflammation, followed by axonal loss, and patchy fascicular lesions. Treatment with corticosteroids, sometimes in combination with other immunosuppressants, is required to control the inflammatory process and prevent further ischemic nerve damage.

      Statements

      CID11:ID_1121924544
      0 references
      dki-india-ID_1121924544
      0 references
      Concluído
      0 references
      13 August 2026
      0 references